Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2008
09/11/2008US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates
09/11/2008DE10340417B4 Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion Cosmetic or dermatological preparation with phytosterols in the form of a W / O emulsion
09/11/2008DE102007011702A1 Aptamer-basierte Reagenzien Aptamer-based reagents
09/11/2008DE102007011486A1 Arzneimittel umfassend wenigstens ein Gestagen A pharmaceutical composition comprising at least one progestin
09/11/2008DE102007011485A1 Darreichungsform mit erschwertem Missbrauch Dosage form with impeded abuse
09/11/2008DE102006050091A1 Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients
09/10/2008EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer
09/10/2008EP1967527A1 A g protein-coupled receptor antagonist and its use for preventing and treating alzheimer s disease
09/10/2008EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application
09/10/2008EP1967522A1 New blood coagulation factor inhibitors
09/10/2008EP1967520A2 Production of polyketides and other natural products
09/10/2008EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity
09/10/2008EP1967517A1 Probe for diagnosis of conformational disease
09/10/2008EP1967516A1 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases
09/10/2008EP1967515A1 Heterocyclic compounds
09/10/2008EP1967513A1 Novel P2Y12 receptor antagonists
09/10/2008EP1967221A2 Method of providing a solution for peritoneal dialysis
09/10/2008EP1967211A1 Method of producing solid preparation disintegrating in the oral cavity
09/10/2008EP1967203A1 Polysaccharide vaccine for staphylococcal infections
09/10/2008EP1967193A1 Enhancement of anticancer therapy by flavonoids
09/10/2008EP1967192A1 N-amidino pyrazinecarboxamide derivatives for use in the prophylaxis or treatment of neurodegenerative diseases
09/10/2008EP1967191A1 Controlled/modified release oral methylphenidate formulations
09/10/2008EP1967190A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those
09/10/2008EP1967189A1 Methods for treating resistant or refractory tumors
09/10/2008EP1967188A1 Pharmaceutical preparation of aqueous solution containing platinum complex
09/10/2008EP1967187A1 Composition based on rutin and L-lysine
09/10/2008EP1967186A1 Composition for soft contact lens and adsorption suppressing method
09/10/2008EP1967184A1 Controlled release solid preparation
09/10/2008EP1967183A1 Controlled release solid preparation
09/10/2008EP1967182A1 Pharmaceutical composition comprising a salt of rosigliatazone
09/10/2008EP1967181A1 Pharmaceutical formulation comprising a CB1-Receptor compound in a solid solution and/or solid dispersion
09/10/2008EP1967180A1 Topical composition comprising a retinoid receptor agonist
09/10/2008EP1967081A1 Process for the manufacture of a powder containing carotenoids
09/10/2008EP1967067A2 Use of neuronal sodium channel antagonists together with amitraz for the control of ectoparasites in homeothermic animals
09/10/2008EP1966378A2 Rnai-mediated inhibition of hif1a for treatment of ocular angiogenesis
09/10/2008EP1966377A2 Modulation of eif4e-bp2 expression
09/10/2008EP1966376A2 Prevention of retroviral infectivity through interference with ppt
09/10/2008EP1966368A2 RNAi-MEDIATED INHIBITION OF IGFlR FOR TREATMENT OF OCULAR ANGIOGENESIS
09/10/2008EP1966227A1 Crystalline forms of ibandronate sodium
09/10/2008EP1966226A2 Azacytosine derivatives useful as antiviral agents
09/10/2008EP1966222A2 Pyrazolothiazole protein kinase modulators
09/10/2008EP1966221A1 Pyrimido- [4, 5-]-oxazines for use as dgat inhibitors
09/10/2008EP1966218A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases
09/10/2008EP1966217A1 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases
09/10/2008EP1966215A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors
09/10/2008EP1966214A1 Triazolopyridazines as tyrosine kinase modulators
09/10/2008EP1966213A1 Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
09/10/2008EP1966212A1 Diazepinones
09/10/2008EP1966211A1 Triazole derivatives
09/10/2008EP1966210A2 Sulphonamidoaniline derivatives being janus kinases inhibitors
09/10/2008EP1966209A1 [ 1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders.
09/10/2008EP1966208A1 (1-aza-bicycloý3.3.1¨n0n-4-yl)-ý5-(ih-indol-5-yl)-heteroaryl¨-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
09/10/2008EP1966207A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/10/2008EP1966204A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them
09/10/2008EP1966203A2 Oxazoloisoquinoline derivatives as thrombin receptor antagonists
09/10/2008EP1966202A1 Heteroaryl substituted pyrroloý2,3-b¨pyridines and pyrroloý2,3-b¨pyrimidines as janus kinase inhibitors
09/10/2008EP1966200A1 Heterocyclic janus kinase 3 inhibitors
09/10/2008EP1966199A1 Azaindole-2-carboxamide derivatives
09/10/2008EP1966196A2 Pure and stable tiotropium bromide
09/10/2008EP1966195A2 5-aryl isoxazolines for controlling invertebrate pests
09/10/2008EP1966194A2 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
09/10/2008EP1966193A1 New salt and polymorph of dpp-iv inhibitor
09/10/2008EP1966192A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/10/2008EP1966191A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
09/10/2008EP1966190A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer
09/10/2008EP1966189A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
09/10/2008EP1966187A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
09/10/2008EP1966185A2 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION
09/10/2008EP1966184A2 Pyridinyl-quinazoline derivatives and their medical use
09/10/2008EP1966183A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/10/2008EP1966182A1 Inhibitors of ccr9 activity
09/10/2008EP1966181A2 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
09/10/2008EP1966179A2 Darifenacin hydrobromide composition substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof
09/10/2008EP1966176A1 Heterocyclic gaba-b modulators
09/10/2008EP1966174A1 Chemical compounds
09/10/2008EP1966172A1 Thiazoles for the treatment of proliferative disorders
09/10/2008EP1966169A2 Compositions and methods for the inhibition of phospholipase a2
09/10/2008EP1966166A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS
09/10/2008EP1966165A1 Pyrazine derivatives as epithelial sodium channel blocker
09/10/2008EP1966164A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases
09/10/2008EP1966163A1 Pyrimidine derivatives useful as inhibitors of pkc-theta
09/10/2008EP1966162A2 Pyrimidine derivatives
09/10/2008EP1966160A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES
09/10/2008EP1966158A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
09/10/2008EP1966156A2 New compounds iii
09/10/2008EP1966155A1 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer
09/10/2008EP1966154A1 Imidazole derivatives for the treatment of gastrointestinal disorders
09/10/2008EP1966152A2 Glucokinase activators
09/10/2008EP1966151A1 Polycyclic indazole derivatives that are erk inhibitors
09/10/2008EP1966150A1 Pyrazoles for the treatment of gerd and ibs
09/10/2008EP1966146A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
09/10/2008EP1966144A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
09/10/2008EP1966143A2 Substituted aniline derivatives useful as histamine h3 antagonists
09/10/2008EP1966142A2 New phenanthridine derivatives as bradykinin antagonists
09/10/2008EP1966141A1 Six-membered heterocycles useful as serine protease inhibitors
09/10/2008EP1966140A1 Process for synthesizing remifentanil
09/10/2008EP1966139A1 Aspartic protease inhibitors
09/10/2008EP1966138A2 Substituted tricyclic piperidone derivatives
09/10/2008EP1966137A2 Piperidine derivatives
09/10/2008EP1966134A1 Novel fused pyrrole derivatives